Tu, Z., Xu, B., Qu, C., Tao, Y., Chen, C., Hua, W., . . . Xia, Y. (2015). BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro. Radiat Oncol.
Styl cytowania ChicagoTu, Ziwei, et al. "BRCC3 Acts As a Prognostic Marker in Nasopharyngeal Carcinoma Patients Treated With Radiotherapy and Mediates Radiation Resistance in Vitro." Radiat Oncol 2015.
Styl cytowania MLATu, Ziwei, et al. "BRCC3 Acts As a Prognostic Marker in Nasopharyngeal Carcinoma Patients Treated With Radiotherapy and Mediates Radiation Resistance in Vitro." Radiat Oncol 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..